(Alliance News) - GSK PLC on Monday said mepolizumab, sold under the brand name Nucala, has been approved in China for use in adults with chronic obstructive pulmonary disease. The London-based ...

Investing.com -- China has approved GSK Plc ’s (LON:GSK) Nucala as an add-on maintenance treatment for adults with chronic ...

Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...

A quasi-experimental study found anticipatory nursing in chronic obstructive pulmonary disease lowered anxiety and depression ...

Objectives In patients with chronic obstructive pulmonary disease (COPD), severe exacerbations (ECOPDs) impose significant morbidity and mortality. Current guidelines emphasise using ECOPD history to ...

Dr. Roach shares a link to a video, but having your doctor watch you use it is the best way to verify you're doing it right.

Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...

In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary ...

COPD inhaled triple therapy (BDP/FF/G) improved symptoms, lung function, adherence, and QOL in patients previously treated with inhaled dual therapy.

Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...

Hollywood was dealt a series of losses this year, from actor Gene Hackman to rocker Ozzy Osbourne. Remembering the year's ...